FDA.reportPublic FDA data

tofacitinib citrate

RxCUI
1358492
RxNorm name
tofacitinib citrate
Term type
PIN
Status
Active
Updated
2026-06-04 07:05:46

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
122012
Active start
122012
Multiple ingredient
NO
Branded
NO

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
tofacitinib1357536

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRtofacitinib citrateNAMES
RxNorm Nametofacitinib citrateNAMES
TTYPINATTRIBUTES
SPL_SET_ID179ffbb2-bedc-40e6-b77b-33d4f7832172CODES
SPL_SET_ID21a89264-8047-40ac-8b10-fa6461072509CODES
SPL_SET_ID68e3d6b2-7838-4d2d-a417-09d919b43e13CODES
SPL_SET_IDac0b26d5-1352-42ff-b5ea-3eb02d8508a4CODES
SPL_SET_IDcb6b5f51-abb9-4c52-a221-7c27cee18ee7CODES
SPL_SET_IDcf74ba2f-afc5-4baa-8594-979c889a5831CODES
SPL_SET_IDe54b186f-e42a-4477-939c-8dd331045fbeCODES
SPL_SET_IDf4d0e580-74a8-496e-89a2-d74478c946bfCODES
UNII_CODEO1FF4DIV0DCODES
RxCUI1358492CODES
MMSL_CODEIN31571CODES

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCL04AFJanus-associated kinase (JAK) inhibitorsATC1-4tofacitinib
FDASPLN0000190858Janus Kinase InhibitorEPChas_epctofacitinib
FDASPLN0000190857Janus Kinase InhibitorsMOAhas_moatofacitinib
MEDRTD010880PiperidinesCHEMhas_ingredienttofacitinib
MEDRTD010880PiperidinesCHEMhas_ingredienttofacitinib citrate
MEDRTD011743PyrimidinesCHEMhas_ingredienttofacitinib
MEDRTD001172Arthritis, RheumatoidDISEASEmay_treattofacitinib
MEDRTD001172Arthritis, RheumatoidDISEASEmay_treattofacitinib citrate
MEDRTN0000190857Janus Kinase InhibitorsMOAhas_moatofacitinib
MEDRTN0000190857Janus Kinase InhibitorsMOAhas_moatofacitinib citrate
MEDRTN0000008656Decreased HematopoiesisPEhas_petofacitinib
MEDRTN0000008656Decreased HematopoiesisPEhas_petofacitinib citrate
MEDRTN0000175550Decreased Immunologic ActivityPEhas_petofacitinib
MEDRTN0000175550Decreased Immunologic ActivityPEhas_petofacitinib citrate

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESTTYPIN
CODESMMSL_CODEIN31571
CODESRxCUI1358492
CODESSNOMEDCT704314009
CODESSPL_SET_ID179ffbb2-bedc-40e6-b77b-33d4f7832172
CODESSPL_SET_ID21a89264-8047-40ac-8b10-fa6461072509
CODESSPL_SET_ID68e3d6b2-7838-4d2d-a417-09d919b43e13
CODESSPL_SET_IDac0b26d5-1352-42ff-b5ea-3eb02d8508a4
CODESSPL_SET_IDcb6b5f51-abb9-4c52-a221-7c27cee18ee7
CODESSPL_SET_IDcf74ba2f-afc5-4baa-8594-979c889a5831
CODESSPL_SET_IDe54b186f-e42a-4477-939c-8dd331045fbe
CODESSPL_SET_IDf4d0e580-74a8-496e-89a2-d74478c946bf
CODESUNII_CODEO1FF4DIV0D
CODESUSPm7987
NAMESRXNAV_STRtofacitinib citrate
NAMESRxNorm Nametofacitinib citrate
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceUnited States Pharmacopeia
SOURCESSourceUS Edition of SNOMED_CT